1. Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland;
2. Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;
3. Dalle Molle Institute for Artificial Intelligence (IDSIA), Manno, Switzerland;
4. Swiss Institute of Bioinformatics, Lausanne, Switzerland;
5. Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
6. Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;
7. Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
8. Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
9. Institute of Applied Biosciences, CERTH, Thessaloniki, Greece;
10. Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Université Lyon 1, Lyon, France;
11. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX;
12. Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden;
13. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE;
14. Department of Hematology Oncology, Hematology Unit and Division of Pathology, University of Pavia, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy;
15. Division of Hematology, University of Modena and Reggio Emilia, Modena, Italy;
16. Department of Pathology, Center for Experimental Research and Medical Studies (CeRMS), University of Turin, Turin, Italy;
17. Division of Hematology, University of Turin, A.O.U. San Giovanni Battista, Turin, Italy;
18. Division of Hematology, University of Siena, Siena, Italy;
19. Pathology, St. Gallen Hospital, St. Gallen, Switzerland;
20. Department of Molecular Genetics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic;
21. Division of Hematopathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA;
22. Department of Internal Medicine III, Ulm University, Ulm, Germany;
23. Hospital Universitario Marques de Valdecilla, Santander, Spain;
24. 1st Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary;
25. Department of Pathology, PathWest Laboratory Medicine WA, Nedlands, Australia;
26. Hematology Research Center of Russia, Moscow, Russian Federation;
27. Department of Pathology, University of Verona, Verona, Italy;
28. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Aviano, Italy;
29. Columbia University Medical Center and New York Presbyterian Hospital, New York, NY; and
30. Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany